Please assess the completion status of the following clinical trial:

Trial Title: Anti-Helicobacter Pylori Antibodies (IgG) in Serum of Women With Unexplained Infertility

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. regular cycles.~2. normal thyroid function, prolactin and androgen levels.~3. normal semen analysis of the partner.~4. normal hysterosalpingography.~5. normal transvaginal ultrasound examination.~Exclusion Criteria:~1. possible uterine malformations or pathologies.~2. presence of infections, including hepatitis, human immunodeﬁciency virus (HIV), TORCH, Chlamydia trachomatis and Mycoplasma.~3. presence of anti-sperm antibodies in serum.~4. Male factor infertility.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- unexplained infertility patients (Type: None): 44 patients diagnosed to have unexplained infertility
- Fertile women (Type: None): 44 fertile women

Based on this trial design, predict the completion outcome and termination type (if applicable).